• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

导管腺癌以及前列腺Gleason 4级筛状和非筛状腺泡腺癌的免疫组织化学抗体组合染色(p63/高分子量细胞角蛋白/α-甲基酰基辅酶A消旋酶)

Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate.

作者信息

Herawi Mehsati, Epstein Jonathan I

机构信息

Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA.

出版信息

Am J Surg Pathol. 2007 Jun;31(6):889-94. doi: 10.1097/01.pas.0000213447.16526.7f.

DOI:10.1097/01.pas.0000213447.16526.7f
PMID:17527076
Abstract

Overexpression of alpha-methylacyl coenzyme A racemase (AMACR) in combination with absence of basal cell markers [ie, p63 and high molecular weight cytokeratin (HMWCK)] is typical of classic acinar prostatic adenocarcinoma. We studied the expression and diagnostic utility of p63/HMWCK/AMACR immunohistochemical cocktail staining in ductal adenocarcinoma and cribriform Gleason pattern 4 acinar prostate cancer and compared it to noncribriform Gleason pattern 4 acinar prostate cancer. One to 4 representative formalin-fixed paraffin-embedded archival tissue blocks from 62 radical prostatectomy specimens harboring prostate cancer of ductal (n=51), cribriform Gleason pattern 4 acinar (n=27), and noncribriform Gleason pattern 4 acinar adenocarcinoma (n=48) were included in this study. Immunohistochemistry was performed using a triple stain of AMACR, p63, and HMWCK. Only staining that was moderate or strong was considered positive. The percentage of staining intensity and the presence of occasional basal cells positive with p63/HMWCK were recorded in each histologic type of prostatic adenocarcinoma. Seventy-seven percent of ductal prostatic adenocarcinoma, 67% of cribriform acinar prostatic carcinoma, and 81% of noncribriform acinar prostatic carcinoma showed positive staining for AMACR. There was no statistically significant difference between AMACR staining among the 3 histologic types, although there was a trend for noncribriform acinar prostatic carcinoma to have greater expression of AMACR than cribriform acinar prostatic carcinoma (P=0.07). Staining was often heterogeneous, varying in staining intensities within the same histologic type of carcinoma. Basal cells were detectable by p63 and HMWCK in a patchy fashion in 31.4% (16/51) of ductal and 29.6% (8/27) of cribriform acinar carcinomas compared with 2.1% (1/48) of noncribriform acinar carcinomas. In summary: (1) the majority of prostatic ductal and cribriform acinar carcinomas strongly expressed AMACR, however, subpopulations of these prostatic carcinoma were either completely negative or only weakly positive; (2) AMACR staining was often heterogeneous in intensity in the same histologic type of tumor, even within the same case; (3) patchy basal cell staining in noncribriform acinar prostatic carcinoma is rare. In contrast, remnants of basal cells identified by p63/HMWCK were seen in a patchy fashion in a significant minority of both ductal and cribriform acinar prostatic adenocarcinoma, which most likely represents intraductal spread of tumor.

摘要

α-甲基酰基辅酶A消旋酶(AMACR)过表达且缺乏基底细胞标志物[即p63和高分子量细胞角蛋白(HMWCK)]是经典腺泡状前列腺癌的典型特征。我们研究了p63/HMWCK/AMACR免疫组化鸡尾酒染色在导管腺癌和筛状Gleason 4级腺泡状前列腺癌中的表达及诊断效用,并将其与非筛状Gleason 4级腺泡状前列腺癌进行比较。本研究纳入了62例前列腺癌根治术标本中具有代表性的1至4个福尔马林固定石蜡包埋存档组织块,这些标本包括导管癌(n = 51)、筛状Gleason 4级腺泡癌(n = 27)和非筛状Gleason 4级腺泡腺癌(n = 48)。采用AMACR、p63和HMWCK三联染色进行免疫组化。仅将中度或强染色视为阳性。记录每种组织学类型的前列腺腺癌中染色强度百分比以及偶尔出现的p63/HMWCK阳性基底细胞情况。77%的导管前列腺癌、67%的筛状腺泡前列腺癌和81%的非筛状腺泡前列腺癌AMACR染色呈阳性。这三种组织学类型之间的AMACR染色无统计学显著差异,尽管非筛状腺泡前列腺癌有比筛状腺泡前列腺癌AMACR表达更高的趋势(P = 0.07)。染色通常不均匀,在同一组织学类型的癌内染色强度有所不同。在31.4%(16/51)的导管癌和29.6%(8/27)的筛状腺泡癌中可呈斑片状检测到p63和HMWCK阳性的基底细胞,相比之下,非筛状腺泡癌中仅2.1%(1/48)有这种情况。总之:(1)大多数前列腺导管癌和筛状腺泡癌强烈表达AMACR,然而,这些前列腺癌的亚群要么完全阴性,要么仅弱阳性;(2)AMACR染色在同一组织学类型的肿瘤内强度通常不均匀,即使在同一病例中也是如此;(3)非筛状腺泡前列腺癌中斑片状基底细胞染色罕见。相比之下,在少数导管和筛状腺泡前列腺腺癌中可呈斑片状见到p63/HMWCK识别的基底细胞残余,这很可能代表肿瘤的导管内播散。

相似文献

1
Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate.导管腺癌以及前列腺Gleason 4级筛状和非筛状腺泡腺癌的免疫组织化学抗体组合染色(p63/高分子量细胞角蛋白/α-甲基酰基辅酶A消旋酶)
Am J Surg Pathol. 2007 Jun;31(6):889-94. doi: 10.1097/01.pas.0000213447.16526.7f.
2
Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.激素治疗后前列腺腺癌中的α-甲基酰基辅酶A消旋酶(P504S)/34βE12/p63三联免疫组化染色
Hum Pathol. 2007 Feb;38(2):332-41. doi: 10.1016/j.humpath.2006.08.016. Epub 2006 Nov 28.
3
False positive labeling of prostate cancer with high molecular weight cytokeratin: p63 a more specific immunomarker for basal cells.高分子量细胞角蛋白对前列腺癌的假阳性标记:p63是一种更具特异性的基底细胞免疫标志物。
Am J Surg Pathol. 2008 Dec;32(12):1890-5. doi: 10.1097/PAS.0b013e31817ce994.
4
Partial atrophy on prostate needle biopsy cores: a morphologic and immunohistochemical study.前列腺穿刺活检组织芯的部分萎缩:一项形态学和免疫组织化学研究。
Am J Surg Pathol. 2008 Jun;32(6):851-7. doi: 10.1097/PAS.0b013e31815a0508.
5
High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.前列腺高级别前列腺上皮内瘤变样导管腺癌:28例临床病理研究
Am J Surg Pathol. 2008 Jul;32(7):1060-7. doi: 10.1097/PAS.0b013e318160edaf.
6
Reliability of the 34βE12, keratin 5/6, p63, bcl-2, and AMACR in the diagnosis of prostate carcinoma.34βE12、角蛋白 5/6、p63、bcl-2 和 AMACR 在前列腺癌诊断中的可靠性。
Urol Oncol. 2011 Nov-Dec;29(6):614-23. doi: 10.1016/j.urolonc.2009.11.013. Epub 2010 Mar 2.
7
Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference.前列腺中免疫组织化学应用的最佳实践建议:国际泌尿病理学会共识会议报告。
Am J Surg Pathol. 2014 Aug;38(8):e6-e19. doi: 10.1097/PAS.0000000000000238.
8
[Detection of AMACR (P504S), P63 and 34betaE12 cocktail in the early diagnosis of prostate cancer].[AMACR(P504S)、P63和34βE12联合检测在前列腺癌早期诊断中的应用]
Zhonghua Nan Ke Xue. 2007 Mar;13(3):222-5.
9
Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.α-甲基酰基辅酶A消旋酶:一种新的前列腺癌分子标志物。
Cancer Res. 2002 Apr 15;62(8):2220-6.
10
The value of triple antibody (34βE12 + p63 + AMACR) cocktail stain in radical prostatectomy specimens with crushed surgical margins.三抗体(34βE12+p63+AMACR)鸡尾酒染色在伴有外科切缘挤压的根治性前列腺切除标本中的价值。
J Clin Pathol. 2012 May;65(5):437-40. doi: 10.1136/jclinpath-2011-200533. Epub 2012 Jan 31.

引用本文的文献

1
Ductal prostate cancer: Clinical features and outcomes from a multicenter retrospective analysis and overview of the current literature.导管前列腺癌:多中心回顾性分析的临床特征与结果及当前文献综述
Curr Urol. 2022 Dec;16(4):218-226. doi: 10.1097/CU9.0000000000000118. Epub 2022 Aug 31.
2
Cribriform Patterned Lesions in the Prostate Gland with Emphasis on Differential Diagnosis and Clinical Significance.前列腺中的筛状病变:着重于鉴别诊断及临床意义
Cancers (Basel). 2022 Jun 21;14(13):3041. doi: 10.3390/cancers14133041.
3
Ductal adenocarcinoma of the prostate: A systematic review and meta-analysis of incidence, presentation, prognosis, and management.
前列腺导管腺癌:发病率、临床表现、预后及治疗的系统评价和荟萃分析
BJUI Compass. 2021 Jan 5;2(1):13-23. doi: 10.1002/bco2.60. eCollection 2021 Jan.
4
Telomere lengths differ significantly between small-cell neuroendocrine prostate carcinoma and adenocarcinoma of the prostate.端粒长度在小细胞神经内分泌前列腺癌和前列腺腺癌之间有显著差异。
Hum Pathol. 2020 Jul;101:70-79. doi: 10.1016/j.humpath.2020.04.014. Epub 2020 May 7.
5
Genomic Characterization of Prostatic Ductal Adenocarcinoma Identifies a High Prevalence of DNA Repair Gene Mutations.前列腺导管腺癌的基因组特征揭示DNA修复基因突变的高发生率。
JCO Precis Oncol. 2019;3. doi: 10.1200/PO.18.00327. Epub 2019 Apr 18.
6
Signature maps for automatic identification of prostate cancer from colorimetric analysis of H&E- and IHC-stained histopathological specimens.基于 H&E 和免疫组化染色组织学标本比色分析的前列腺癌自动识别特征图谱。
Sci Rep. 2019 May 6;9(1):6992. doi: 10.1038/s41598-019-43486-y.
7
Intraductal carcinoma of the prostate: a critical re-appraisal.前列腺导管内癌:批判性再评价。
Virchows Arch. 2019 May;474(5):525-534. doi: 10.1007/s00428-019-02544-6. Epub 2019 Mar 1.
8
Patient-derived Models Reveal Impact of the Tumor Microenvironment on Therapeutic Response.患者来源模型揭示肿瘤微环境对治疗反应的影响。
Eur Urol Oncol. 2018 Sep;1(4):325-337. doi: 10.1016/j.euo.2018.04.019. Epub 2018 Jun 6.
9
Comedonecrosis Revisited: Strong Association With Intraductal Carcinoma of the Prostate.再次审视前列腺小囊脓肿:与前列腺导管内癌强烈相关。
Am J Surg Pathol. 2018 Aug;42(8):1036-1041. doi: 10.1097/PAS.0000000000001104.
10
MSH2 Loss in Primary Prostate Cancer.原发性前列腺癌中 MSH2 的缺失。
Clin Cancer Res. 2017 Nov 15;23(22):6863-6874. doi: 10.1158/1078-0432.CCR-17-0955. Epub 2017 Aug 8.